Lipid peroxidation and protein modification in a mouse model of chronic iron overload

Metabolism: Clinical and Experimental

Volumn 51, Issue 5, 2002, Pages 645-651

  Sochaski, Mark A ^a,b,c,d   Bartfay, Wally J ^a,b,c,d   Thorpe, Suzanne R ^a,b,c,d   Baynes, John W ^a,b,c,d   Bartfay, Emma ^a,b,c,d   Lehotay, Denis C ^a,b,c,d   Liu, Peter P ^a,b,c,d  

^a UNIVERSITY OF SOUTH CAROLINA   (United States)

^b QUEEN S UNIVERSITY   (Canada)

^c Saskatchewan Ministry of Health   (Canada)

^d UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYNONENAL LYSINE; ALDEHYDE; BIOLOGICAL MARKER; BUTYRALDEHYDE; CARBONYL DERIVATIVE; COLLAGEN; FURFURAL; GLUTATHIONE PEROXIDASE; IRON DEXTRAN; LIVER ENZYME; LIVER PROTEIN; LYSINE DERIVATIVE; MALONALDEHYDE; MALONALDEHYDE LYSINE; METHIONINE SULFOXIDE; PROPIONALDEHYDE; PROTEIN; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; CHEMICAL MODIFICATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE MARKER; ENZYME ACTIVITY; HEMOSIDEROSIS; IRON OVERLOAD; IRON STORAGE; LIPID PEROXIDATION; LIVER CELL; LONG TERM CARE; MALE; MOUSE; NONHUMAN; OXIDATION; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN MODIFICATION; SENSITIVITY AND SPECIFICITY;

EID: 0036252489     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1053/meta.2002.30530     Document Type: Article

References (64)

1. Most free radical injury is iron mediated: It is promoted by iron, hemin, holoferritin and vitamin C, and inhibited by desferroxamine and apoferritin
2. Effects of positive iron status at a cellular level
3. Hereditary hemochromatosis: Etiologic, pathological and clinical aspects
4. Secondary iron-overload disorders
5. The relationship between iron overload, clinical symptoms and age in 410 patients with genetic hemochromatosis
6. Management of hemochromatosis: Hemochromatosis Management Working Group
7. Iron overload in Sub-Saharan Africa: To what extent is it a public health problem?
8. Tissue iron overload and mechanisms of iron-catalyzed oxidative injury
9. Oxidative mechanisms in the toxicity of metal ions
10. In vivo formation of hydroxyl radicals following intragastric administration of ferrous salts in rats
11. Electron spin resonance spin-trapping investigation into the effects of paraquat and desferrioxamine on hydroxyl radical generation during acute iron poisoning
12. Direct evidence for in vivo hydroxyl radical generation in experimental iron overload: An ESR spin-trapping investigation
13. Liver injury and generation of hydroxyl free radicals in experimental secondary hemochromatosis
14. A unique rodent model for both the cardiotoxic and hepatotoxic effects of prolonged iron-overload
15. The effect of iron-overload on rat plasma and liver oxidant status in vivo
16. Cellular and molecular responses in the Sprague-Dawley rat to chronic iron overload
17. Cardiac function and cytotoxic aldehyde production in a murine model of chronic iron-overload
18. A biochemical and histochemical, and electron microscopic study on the effects of iron loading in heart of mice
19. The cardioprotective effects of selenium and morin hydrate in a murine model of chronic iron-overload
20. Low-molecular-weight iron complexes and oxygen radical reactions in idiopathic haemochromatosis
21. Antioxidant status and lipid peroxidation in hereditary hemochromatosis
22. Excess iron induces hepatic oxidative stress and transforming growth factor beta 1 in genetic hemochromatosis
23. Platelet derived malondialdehyde production in patients with thalassemia major
24. Oxidative stress and antioxidant status in beta-thalassemia major: Iron overload and depletion of lipid soluble antioxidants
25. Solid-phase extraction in malondialdehyde analysis
26. Renal function in adult β-thalassemia/HbE disease
27. Comparison of cytotoxic aldehyde generation in beta-thalassemia patients chelated with deferoxamine or deferiprone versus no chelation
28. Free-iron and iron toxicity in iron overload
29. Non-transferrin bound iron in plasma or serum from patients with idiopathic hemochromatosis. Characterization by high performance liquid chromatography and nuclear magnetic resonance spectroscopy
30. Serum non-transferrin-bound iron in beta thalassemia major patients treated with desferrioxamine and L1
31. Age-dependent accumulation of ortho-tyrosine and methionine sulfoxide in human skin collagen is not increased in diabetes: Evidence against a generalized increase in oxidative stress in diabetes
32. Quantification of malondialdehyde and 4-hydroxynonenal adducts to lysine residues in native and oxidized human low-density lipoproteins
33. ε-(carboxymethyl)lysine, is a product of both lipid peroxidation and glycoxidation reactions
34. Canadian council on animal care. Guide to the care and use of experimental animals
35. Quantification of cardiac and tissue iron by nuclear magnetic resonance relaxometry in a novel murine thalassemia-cardiac iron overload model
36. Magnetic-susceptibility measurement of human iron stores
37. The synergistic effects of vitamin E and selenium in iron-overloaded mouse hearts
38. Determination of aldehydes and other lipid peroxidation products in biological samples by gas chromatography-mass spectrometry
39. Cytotoxic aldehydes as possible markers for childhood cancer
40. Chromatographic evidence for Amadori product formation in rat liver aminophospholipids
41. ε-(carboxymethyl)hydroxylysine in human skin collagen
42. Simplified protein hydrolysis with methanesulphonic acid at elevated temperature for the complete amino acid analysis of protein
43. Complete mass spectra of the pertrimethyl-silylated amino acids
44. Isotope dilution gas chromatography/mass spectrometry method for the determination of methionine sulfoxide in protein
45. High incidence of cardiomyopathy in beta-thalassemia patients receiving regular transfusion and iron chelation: Reversal by intensified chelation
46. Iron overload. Prevalence and impact on health
47. Iron-chelating therapy and the treatment of thalassemia
48. Malondialdehyde and 4-hydroxynonenal protein adducts in plasma and liver of rats with iron overload
49. Methionine residues may protect proteins from critical oxidative damage
50. Oxidation of methionine residues in proteins: Tools, targets, and reversal
51. Overexpression of peptide-methionine sulfoxide reductase in Saccharomyces cerevisiae and human T cells provides them with high resistance to oxidative stress
52. Accumulation of Maillard reaction products in skin collagen in diabetes and aging
53. Influence of vitamin E and selenium on glutathione peroxidase dependent protection against microsomal lipid peroxidation
54. The role of selenium in the protection of membranes against oxidative damage of membranes
55. Importance of Seglutathione peroxidase, catalase, and Cu/Zn-SOD for cell survival against oxidative stress
56. Ferric iron and superoxide ions are required for the killing of cultured hepatocytes by hydrogen peroxide-evidence for the participation of hydroxyl radicals formed by iron-catalyzed Haber Weiss reaction
57. Nitroxide stable radicals protects beating cardiomyocytes against oxidative damage
58. Hydrogen peroxide cytotoxicity is iron dependent
59. 4-Hydroxynonenal inhibits glutathione peroxidase: Protection by glutathione
60. Hepatic chemiluminescence and lipid peroxidation in mild iron overload
61. Effect of iron overload in the isolated ischemic and reperfused rat heart
62. Diabetic nephropathy in hypertransfused patients with beta-thalassemia
63. Transcriptional regulator of oxidative stress inducible genes: Direct activation by oxidation
64. Alternation of antioxidant enzymes with aging in rat skeletal muscle and liver